You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
Trading
Institutions
Fees
Promotions
Help Center
uSMARTPORT
Download
About
Hong Kong
uSMART
EN
Login/Register
Market News

Market News

HomeMarket NewsInformation about Individual Stocks

CStone Pharmaceuticals (02616)

CStone Pharmaceuticals, a biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally. The company offers CEJEMLY (sugemalimab), a monoclonal antibody against programmed death (PD) ligand 1 for the treatment of non-small cell lung cancer (NSCLC), gastric adenocarcinoma/gastroesophageal junction adenocarcinoma, esophageal

Business Collaboration
Register now

Services

FeesFAQExclusive Trading Tools

About Us

OverviewContact UsMedia Center

Agreement Statement

DisclaimerPrivacy Statement
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
Email: cs@usmart.hk
WhatsApp: +852 5989 2641
uSMART-Facebook-Page
Headquarters
Sheung Wan
Address:
Room 2405-06, 24/F, 308 Central Des Voeux, Sheung Wan, Hong Kong
(3-mins walk from MTR Sheung Wan Station Exit A2)
North District
Address:
1718-1721, Level 17 Landmark North, 39 Lung Sum Avenue, Sheung Shui, New Territories, Hong Kong
(Steps away from MTR Sheung Shui Station Exit A4)
Wealth Center
AdmiraltyComing Soon
Address:
Room 2602B, 26/F, Tower 1, Lippo Centre, 89 Queensway, Admiralty, Hong Kong
uSMART Branches
uSmart Securities Limited
is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907) holding Type 1 Licence for Dealing in Securities, Type 4 Licence for Advising on Securities, Type 6 Licence for Advising on Corporate Finance, and Type 9 Licence for Asset Management.

Copyright © 2022 uSMART . All Rights Reserved.